Uremic vascular biology (including both dialysis vascular access dysfunction and cardiovascular complications in kidney disease patients)
Education and Experience
MBBS: Armed Forces Medical College, Pune, India, 1985; MSc: University of Aberdeen, Scotland, UK, 1986; Resident: University of Aberdeen, 1987-1989; Resident: University of Cincinnati, 1996-1998; Nephrology Fellow: University of Aberdeen, Scotland, 1989-1990; Nephrology Fellow: Beth Israel Hospital, Harvard Medical School, Boston, MA, 1993-1996; PhD Candidate: University of Aberdeen, Scotland, United Kingdom, 1990-1993, PhD Renal Medicine 1997; Staff Physician: Veterans Administration Medical Center, Cincinnati 1998-2003 and 2008-2015; FRCP (Edin): Royal College of Physicians, Edinburgh, Scotland, 2000; Assistant Professor of Medicine: University of Cincinnati, 1998-2002 and Associate Professor of Medicine, 2002-2008; Professor of Medicine: University of Cincinnati, Cincinnati, OH, 2008-2015; Professor of Biomedical Engineering: University of Cincinnati, 2008-2015; Section Head: Dialysis Vascular Access, University of Cincinnati, 2013-2015; Professor of Medicine and Division Director, Nephrology: University of Arizona and Banner University Medical Centers-Tucson and South, Tucson, AZ, 2015-2018; Staff Nephrologist, Southern Arizona VA Healthcare System, 2015-2019; Professor of Medicine, University of North Carolina, and Co-Director, UNC Kidney Center: 2019-present.
Clinical and Research Interests
Dr. Roy-Chaudhury currently leads a translational research program in uremic vascular biology funded through the National Institutes of Health, the Veterans Administration research program, and through industry grants. He has published over 175 papers, and is a sought after invited speaker, both nationally and internationally.
He has also been actively involved in the public policy and administrative aspects of dialysis vascular access care and hemodialysis as a previous or current board member/councilor/committee chair for the American Society of Diagnostic and Interventional Nephrology, the Renal Network, the Interventional Nephrology Advisory Group of the American Society of Nephrology (ASN), the ASN Board of Advisors and Capitol Hill advocacy team, the ASN Post Graduation Education Committee and the International Society of Nephrology-India and South Asia Committees, as well as being the previous President of the American Nephrologists of Indian Origin (ANIO).
Dr. Roy-Chaudhury was also the founding American Society of Nephrology co-chair of the Kidney Health Initiative, which is a public-private partnership between the ASN and the FDA, which aims to bring together nephrologists, industry partners, patient advocacy groups and regulatory agencies; in an attempt to facilitate the passage of drugs, devices and biologics into the kidney disease space. In 2019, he was elected to the ASN Council which is a nine member apex leadership body for the American Society of Nephrology which has over 18,000 members.